Morgan Stanley’s First Trust Indxx Medical Devices ETF MDEV Stock Holding History

Morgan Stanley’s Portfolio MDEV Stock Details MDEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-188	Closed	-$5K	–	8052
2021 Q4	$5K	Buy	+188	New	+$4.87K	﹤0.01%	7644

Other funds holding MDEV

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

JAWM

J. Arnold Wealth Management Youngstown, Ohio $294M AUM 33.6% 1-Year Est. Return

Morgan Stanley's MDEV Position: Q1 2022 in Review

Morgan Stanley sold out of First Trust Indxx Medical Devices ETF (MDEV) in Q1 2022, closing a stake of 188 shares — an estimated $5K sold.

Morgan Stanley first reported a position in MDEV in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 4 funds tracked by Wall St. Rank hold MDEV as of Q1 2022.

Morgan Stanley reported no remaining First Trust Indxx Medical Devices ETF position as of Q1 2022 after selling out during the quarter.
Morgan Stanley sold 188 First Trust Indxx Medical Devices ETF shares in Q1 2022, an estimated $5K.
Morgan Stanley first reported a position in First Trust Indxx Medical Devices ETF in Q4 2021 and held it in 1 quarter.
Morgan Stanley's First Trust Indxx Medical Devices ETF position peaked at $5K in Q4 2021.
4 funds tracked by Wall St. Rank held First Trust Indxx Medical Devices ETF as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.